1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Invasiveness, Neoplasm in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Lash, GE; Liu, Y; Qian, Y; Shi, K; Su, Y; Wang, Q; Xuan, X | 1 |
| Cho, KD; Im, SY; Jang, KY; Kim, HA; Kim, HK; Kim, KJ; Lee, HK | 1 |
| Endo-Sakamoto, Y; Fukumoto, C; Kasamatsu, A; Ogawara, K; Shida-Sakazume, T; Shiiba, M; Shimada, K; Tanzawa, H; Unozawa, M; Uzawa, K; Yokoe, H | 1 |
| Bar-Eli, M; Melnikova, VO | 1 |
| Calorini, L; Fallani, A; Gabellieri, S; Mannini, A; Mugnai, G; Ruggieri, S | 1 |
| Barletta, E; Mugnai, G; Ruggieri, S | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Inflammation and melanoma metastasis.
Topics: Chemokines; Disease Progression; Humans; Immune System; Inflammation; Interleukins; Keratinocytes; Melanoma; Neoplasm Invasiveness; Neoplasm Metastasis; Platelet Activating Factor; Platelet Activation; Receptor, PAR-1; Stromal Cells | 2009 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Indoles; Metabolome; Metabolomics; Middle Aged; Neoplasm Invasiveness; Phenylalanine; Platelet Activating Factor; Tryptophan; Tumor Necrosis Factor-alpha | 2018 |
Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-κB activation.
Topics: Animals; Blotting, Western; Casein Kinase II; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Enzyme Activation; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; NF-kappa B; Platelet Activating Factor; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction | 2014 |
Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mouth; Mouth Neoplasms; Neoplasm Invasiveness; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2015 |
Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line.
Topics: Animals; Azepines; Cell Movement; Collagen; Culture Media, Conditioned; Drug Combinations; Interferon-gamma; Laminin; Melanoma; Mice; Neoplasm Invasiveness; Phenotype; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proteoglycans; Receptors, G-Protein-Coupled; Stress Fibers; Time Factors; Triazoles; Tumor Cells, Cultured | 2006 |
Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones.
Topics: Cell Differentiation; Clone Cells; Collagen; Drug Combinations; Humans; Laminin; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Neoplasm Invasiveness; Neuroblastoma; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteoglycans; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Tumor Cells, Cultured | 2002 |